Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Valvular Heart Disease

  Free Subscription


04.03.2019

1 Catheter Cardiovasc Interv
1 Clin Cardiol
4 Eur J Cardiothorac Surg
4 Heart
3 Int J Cardiol
1 J Am Soc Echocardiogr
2 J Thorac Cardiovasc Surg
1 Pediatr Cardiol
2 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Catheter Cardiovasc Interv

  1. UESHIMA D, Masiero G, Schiavo A, Badawy MRA, et al
    Time course of the survival advantage of transcatheter over surgical aortic valve replacement: Interplay between sex and patient risk profile.
    Catheter Cardiovasc Interv. 2019 Feb 28. doi: 10.1002/ccd.28124.
    PubMed     Text format     Abstract available


    Clin Cardiol

  2. ROSSEEL L, Bieliauskas G, Brodersen BB, Olsen PS, et al
    Patients and informal caregivers' experience of surgical and transcatheter aortic valve replacement: real-world data contributing to establish value-based medicine in Denmark.
    Clin Cardiol. 2019 Feb 28. doi: 10.1002/clc.23166.
    PubMed     Text format     Abstract available


    Eur J Cardiothorac Surg

  3. BERRETTA P, Andreas M, Carrel TP, Solinas M, et al
    Minimally invasive aortic valve replacement with sutureless and rapid deployment valves: a report from an international registry (Sutureless and Rapid Deployment International Registry)dagger.
    Eur J Cardiothorac Surg. 2019 Feb 28. pii: 5366940. doi: 10.1093.
    PubMed     Text format     Abstract available

  4. MOSCARELLI M, Fattouch K, Speziale G, Nasso G, et al
    A meta-analysis of the performance of small tissue versus mechanical aortic valve prostheses.
    Eur J Cardiothorac Surg. 2019 Feb 27. pii: 5366204. doi: 10.1093.
    PubMed     Text format     Abstract available

  5. THEOCHARIS P, Viola N, Papamichael ND, Kaarne M, et al
    Echocardiographic predictors of reoperation for subaortic stenosis in children and adults.
    Eur J Cardiothorac Surg. 2019 Feb 25. pii: 5364618. doi: 10.1093.
    PubMed     Text format     Abstract available

  6. COLLI A, Besola L, Bizzotto E, Fiocco A, et al
    Mechanisms of recurrent regurgitation after transapical off-pump mitral valve repair with neochord implantationdagger.
    Eur J Cardiothorac Surg. 2019 Feb 25. pii: 5364609. doi: 10.1093.
    PubMed     Text format     Abstract available


    Heart

  7. WADIA SK, Lluri G, Aboulhosn JA, Shivkumar K, et al
    Ventricular arrhythmia burden after transcatheter versus surgical pulmonary valve replacement.
    Heart. 2018 Apr 10. pii: heartjnl-2017-312769. doi: 10.1136/heartjnl-2017-312769
    PubMed     Text format     Abstract available

  8. OTTO CM
    Mind the gap: missed valve disease diagnosis.
    Heart. 2018;104:1810-1811.
    PubMed     Text format    

  9. RAMCHAND J, Sampaio Rodrigues T, Yudi MB, Burrell LM, et al
    Further studies needed before using renin-angiotensin-aldosterone system blockade for atrial fibrillation prevention in hypertrophic cardiomyopathy.
    Heart. 2018;104:1985.
    PubMed     Text format    

  10. HUANG CY, Lin LY
    Reply: further studies needed before using renin-angiotensin-aldosterone system blockade for atrial fibrillation prevention in hypertrophic cardiomyopathy.
    Heart. 2018;104:1985-1986.
    PubMed     Text format    


    Int J Cardiol

  11. TOGGWEILER S
    Stent grafts to treat access-related vascular injury during transcatheter aortic valve implantation are safe, effective and durable.
    Int J Cardiol. 2019;281:47-48.
    PubMed     Text format    

  12. LEONARD JR, Di Franco A, Gaudino M
    Authors' reply to Preoperative CT scan for Postoperative Stroke Prediction in Minimally Invasive Mitral Valve Surgery: Statistical Concern for Clinical Factors in Regression analyses.
    Int J Cardiol. 2019;281:157.
    PubMed     Text format    

  13. LOU B, Zhou C
    Preoperative CT scan for postoperative stroke prediction in minimally invasive mitral valve surgery: Statistical concern for clinical factors in regression analyses.
    Int J Cardiol. 2019;281:156.
    PubMed     Text format    


    J Am Soc Echocardiogr

  14. ZOGHBI WA, Asch FM, Bruce C, Gillam LD, et al
    Guidelines for the Evaluation of Valvular Regurgitation After Percutaneous Valve Repair or Replacement: A Report from the American Society of Echocardiography Developed in Collaboration with the Society for Cardiovascular Angiography and Interventions
    J Am Soc Echocardiogr. 2019 Feb 20. pii: S0894-7317(19)30003.
    PubMed     Text format    


    J Thorac Cardiovasc Surg

  15. BOTHE W, Escobar Kvitting JP, Rausch MK, Timek TA, et al
    Do annuloplasty rings designed to treat ischemic/functional mitral regurgitation alter left-ventricular dimensions in the acutely ischemic ovine heart?
    J Thorac Cardiovasc Surg. 2019 Jan 11. pii: S0022-5223(19)30004.
    PubMed     Text format     Abstract available

  16. BUZZATTI N, Van Hemelrijck M, Denti P, Ruggeri S, et al
    Transcatheter or surgical repair for degenerative mitral regurgitation in elderly patients: A propensity-weighted analysis.
    J Thorac Cardiovasc Surg. 2019 Jan 22. pii: S0022-5223(19)30232.
    PubMed     Text format     Abstract available


    Pediatr Cardiol

  17. BHATT SM, Elci OU, Wang Y, Goldmuntz E, et al
    Determinants of Exercise Performance in Children and Adolescents with Repaired Tetralogy of Fallot Using Stress Echocardiography.
    Pediatr Cardiol. 2019;40:71-78.
    PubMed     Text format     Abstract available


    PLoS One

  18. KIM SA, Kang MK, Shim CY, Lee S, et al
    Changes of body composition after valve surgery in patients with mitral valve disease.
    PLoS One. 2018;13:e0203798.
    PubMed     Text format     Abstract available

  19. MATA-MBEMBA D, Labani A, El Ghannudi S, Jeung MY, et al
    320-row CT transcatheter aortic valve replacement planning with a single reduced contrast media bolus injection.
    PLoS One. 2018;13:e0204145.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Valvular Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: